Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 [Yahoo! Finance]